Pemphigus vulgaris is the most common autoimmune bullous disease in Northwestern Romania

International Journal of Dermatology

Volumn 49, Issue 7, 2010, Pages 768-774

  Baican, Adrian ^a   Baican, Corina ^a   Chiriac, Gabriela ^a   Chiriac, Mircea T ^b,c,e   Macovei, Victorina ^a   Zillikens, Detlef ^b,c   Ciuce, Dorina ^a   Sitaru, Cassian ^b,c,d  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e BABE BOLYAI UNIVERSITY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOIMMUNE BULLOUS SKIN DISEASE; AUTOIMMUNE DISEASE; BLISTER; BULLOUS PEMPHIGOID; BULLOUS SKIN DISEASE; CONTROLLED STUDY; FEMALE; GENETICS; HISTOLOGY; HUMAN; IMMUNOHISTOLOGY; MAJOR CLINICAL STUDY; MALE; PEMPHIGUS VULGARIS; PROSPECTIVE STUDY; ROMANIA; SEROLOGY; WESTERN EUROPE; BLOOD; IMMUNOLOGY; INCIDENCE; LIFE EXPECTANCY; MIDDLE AGED; MUCOSA; PATHOLOGY; PEMPHIGUS; PREVALENCE;

AUTOANTIBODY; DESMOGLEIN 3; DSG3 PROTEIN, HUMAN;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; DESMOGLEIN 3; FEMALE; HUMANS; INCIDENCE; LIFE EXPECTANCY; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PEMPHIGOID, BULLOUS; PEMPHIGUS; PREVALENCE; ROMANIA;

EID: 77954148573     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.04345.x     Document Type: Article

References (49)

1. Sitaru C, Zillikens D. Mechanisms of blister induction by autoantibodies. Exp Dermatol 2005, 14:861-875.
2. Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med 2007, 11:462-481.
3. Stanley JR, Amagai M. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 2006, 355:1800-1810.
4. Pisanti S, Sharav Y, Kaufman E, Posner LN. Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion. Oral Surg Oral Med Oral Pathol 1974, 38:382-387.
5. Simon DG, Krutchkoff D, Kaslow RA, Zarbo R. Pemphigus in Hartford County, Connecticut, from 1972 to 1977. Arch Dermatol 1980, 116:1035-1037.
6. Hietanen J, Salo OP. Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 1969 and 1978. Acta Derm Venereol 1982, 62:491-496.
7. Bastuji-Garin S, Souissi R, Blum L. Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women. J Invest Dermatol 1995, 104:302-305.
8. Mahe A, Flageul B, Cisse I. Pemphigus in Mali: a study of 30 cases. Br J Dermatol 1996, 134:114-119.
9. Micali G, Musumeci ML, Nasca MR. Epidemiologic analysis and clinical course of 84 consecutive cases of pemphigus in eastern Sicily. Int J Dermatol 1998, 37:197-200.
10. Tsankov N, Vassileva S, Kamarashev J. Epidemiology of pemphigus in Sofia, Bulgaria. A 16-year retrospective study (1980-1995). Int J Dermatol 2000, 39:104-108.
11. Tallab T, Joharji H, Bahamdan K. The incidence of pemphigus in the southern region of Saudi Arabia. Int J Dermatol 2001, 40:570-572.
12. Hahn-Ristic K, Rzany B, Amagai M. Increased incidence of pemphigus vulgaris in southern Europeans living in Germany compared with native Germans. J Eur Acad Dermatol Venereol 2002, 16:68-71.
13. Nanda A, Dvorak R, Al-Saeed K. Spectrum of autoimmune bullous diseases in Kuwait. Int J Dermatol 2004, 43:876-881.
14. Golusin Z, Poljacki M, Jovanovic M. Some epidemiological features of pemphigus chronicus in South Vojvodina: a 12-year retrospective study. Int J Dermatol 2005, 44:792-793.
15. Salmanpour R, Shahkar H, Namazi MR, Rahman-Shenas MR. Epidemiology of pemphigus in south-western Iran: a 10-year retrospective study (1991-2000). Int J Dermatol 2006, 45:103-105.
16. Asilian A, Yoosefi A, Faghini G. Pemphigus vulgaris in Iran: epidemiology and clinical profile. Skinmed 2006, 5:69-71.
17. Uzun S, Durdu M, Akman A. Pemphigus in the Mediterranean region of Turkey: a study of 148 cases. Int J Dermatol 2006, 45:523-528.
18. Michailidou EZ, Belazi MA, Markopoulos AK. Epidemiologic survey of pemphigus vulgaris with oral manifestations in northern Greece: retrospective study of 129 patients. Int J Dermatol 2007, 46:356-361.
19. V'Lckova-Laskoska MT, Laskoski DS, Kamberova S. Epidemiology of pemphigus in Macedonia: a 15-year retrospective study (1990-2004). Int J Dermatol 2007, 46:253-258.
20. Chams-Davatchi C, Valikhani M, Daneshpazhooh M. Pemphigus: analysis of 1209 cases. Int J Dermatol 2005, 44:470-476.
21. Zillikens D, Wever S, Roth A. Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 1995, 131:957-958.
22. Bernard P, Vaillant L, Labeille B. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 1995, 131:48-52.
23. Kyriakis KS, Panteleos DN, Tosca AD. Sunlight and air temperature affect autoantibody activity and skin involvement of bullous pemphigoid. Int J Dermatol 1996, 35:498-501.
24. Jung M, Kippes W, Messer G. Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence. J Am Acad Dermatol 1999, 41:266-268.
25. Cozzani E, Parodi A, Rebora A. Bullous pemphigoid in Liguria: a 2-year survey. J Eur Acad Dermatol Venereol 2001, 15:317-319.
26. Wong SN, Chua SH. Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review. Br J Dermatol 2002, 147:476-480.
27. Wong SN, Chua SH. Bullous pemphigoid seen at the National Skin Centre: a 2-year retrospective review. Ann Acad Med Singapore 2002, 31:170-174.
28. Mulyowa GK, Jaeger C, Oostingh GJ. Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients. Int J Dermatol 2006, 45:1047-1052.
29. Nanda A, Al-Saeid K, Al-Sabah H. Clinicoepidemiological features and course of 43 cases of bullous pemphigoid in Kuwait. Clin Exp Dermatol 2006, 31:339-342.
30. Gudi VS, White MI, Cruickshank N. Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland. Br J Dermatol 2005, 153:424-427.
31. Serwin AB, Bokiniec E, Piascik M. Epidemiological and clinical analysis of pemphigoid patients in northeastern Poland in 2000-2005. Med Sci Monit 2007, 13:CR360-CR364.
32. Langan SM, Smeeth L, Hubbard R. Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study. BMJ 2008, 337:a180.
33. Pfutze M, Niedermeier A, Hertl M, Eming R. Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus. Eur J Dermatol 2007, 17:4-11.
34. Daneshpazhooh M, Chams-Davatchi C, Khamesipour A. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity. J Eur Acad Dermatol Venereol 2007, 21:1319-1324.
35. Schmidt E, Obe K, Bröcker EB, Zillikens D. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 2000, 136:174-178.
36. Sitaru C, Powell J, Messer G. Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis. Obstet Gynecol 2004, 103:757-763.
37. Sitaru C, Kromminga A, Hashimoto T. Autoantibodies to type VII collagen mediate Fcgamma-dependent granulocyte activation and induce dermal-epidermal separation in cryosections of human skin. Am J Pathol 2002, 161:301-311.
38. Chiriac MT, Roesler J, Sindrilaru A. NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. J Pathol 2007, 212:56-65.
39. Ishii K, Amagai M, Hall RP. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol 1997, 159:2010-2017.
40. Zillikens D, Mascaro JM, Rose PA. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol 1997, 109:679-683.
41. Sitaru C, Powell J, Shimanovich I. Pemphigoid gestationis: maternal sera recognise epitopes restricted to the N-terminal portion of the extracellular domain of BP180 not present on its shed ectodomain. Br J Dermatol 2003, 149:420-422.
42. Hashimoto T, Amagai M, Watanabe K. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 1995, 104:829-834.
43. Brenner S, Mashiah J, Tamir E. PEMPHIGUS: an acronym for a disease with multiple etiologies. Skinmed 2003, 2:163-167.
44. Amagai M, Tsunoda K, Zillikens D. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 1999, 40:167-170.
45. Jamora MJ, Jiao D, Bystryn JC. Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris. J Am Acad Dermatol 2003, 48:976-977.
46. Shinkuma S, Nishie W, Shibaki A. Cutaneous pemphigus vulgaris with skin features similar to the classic mucocutaneous type: a case report and review of the literature. Clin Exp Dermatol 2008, 33:724-728.
47. Kobayashi M, Amagai M, Kuroda-Kinoshita K. BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci 2002, 30:224-232.
48. Yoshida M, Hamada T, Amagai M. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid. J Dermatol Sci 2006, 41:21-30.
49. Bertram F, Brocker EB, Zillikens D, Schmidt E. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 2009, 7:434-40.